Open R&D Consortia: Open Innovation Alliances in the Pharmaceutical Industry

制药业在改善人类健康方面发挥着至关重要的作用。在过去的20年里，老牌企业面临着其研发工作的效率和效力不断下降的问题。为此，成立了几十个由工业界支持的研发联合体，以创造知识，并在包括大小企业、大学和其他研究机构在内的私营和公共参与者之间分享知识。本项目将研究这些联盟，以及企业如何协调联盟的开放性与传统的基于知识产权的商业模式。该项目提供了理论见解，了解财团式的研发合作，也为评估新的研发方法在制药行业。 该项目将与财团和其他公私伙伴关系的领导人直接相关。 最后，为这些联盟传播最佳实践将有助于生物医学公司从这种合作中获得最大利益，加速改善人类健康的可用性。该项目将首次对开放式研发联盟进行大规模研究，作为制药行业的一种新的合作形式。该项目将建立一个公共使用的数据库和基于档案数据的研发联盟类型。 访谈将被用来提供详细的案例研究，将探讨知识产权问题，知识占用和战略联盟的实施和运作的研发联盟。深入了解企业如何在开放式创新环境中管理信息流，有可能为管理者和决策者做出重大贡献。

The pharmaceutical industry provides a crucial role in improving human health. Over the past 20 years established firms have faced declining efficiency and effectiveness of their R&D efforts. In response, dozens of industry-supported R&D consortia have been formed to create and share knowledge between private and public participants, which include large and small firms, universities and other research institutes. This project will study these consortia and how firms reconcile the open nature of consortia with their traditional IP-based business models. The project offers theoretical insights for understanding consortia-style R&D collaboration and also for assessing new R&D approaches in the pharmaceutical industry. The project will have direct relevance for leaders of consortia and other public-private partnerships. Finally, disseminating best practice for these consortia will help maximize the benefits that biomedical firms gain from such collaborations, accelerating the availability of improvements in human health. This project will offer the first large-scale study of the open R&D consortia as a new form of cooperation in the pharmaceutical industry. The project will create a public use database and typology of R&D consortium based on archival data. Interviews will be used to provide detailed case studies that will examine intellectual property issues, knowledge appropriation and strategic alliances in the implementation and operation of R&D consortium. A deeper understanding of how firms manage the flow of information in open innovation contexts has the potential to make a significant contribution for managers and policy makers.